Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
Date:2/10/2011

ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2010.

"2010 has been an exceptional milestone year in the history of our company.  Our first product, Fanapt®, reached the U.S. market for the treatment of schizophrenia, we had our first profitable year and we have advanced our second asset, tasimelteon, in Phase 3 studies," said Mihael Polymeropoulos, M.D., President and Chief Executive Officer. "2011 will be a foundation year for Vanda, as we begin to execute upon our vision of building a world class neuroscience pharmaceutical company."

Key Highlights:

  • Vanda recorded 2010 revenue of $35.2 million including royalties and product sales of $8.4 million.  
  • Cash and cash equivalents plus marketable securities at year end 2010 were $198.0 million as compared to $205.3 million at year end 2009.
  • Monthly prescriptions of Fanapt®, as reported by IMS, increased from over 6,000 in September of 2010 to over 8,000 in December of 2010. For the full year 2010, more than 55,000 prescriptions have been written.
  • Tasimelteon efficacy and safety studies are ongoing in both the U.S. and Europe.
  • On November 15, 2010, Vanda received a private letter ruling (PLR) from the Internal Revenue Service (IRS) clarifying the company's ability to utilize net operating loss carryforwards for tax purposes.  

  • Full Year 2010 Reported ResultsTotal revenues for the full year 2010 were $35.2 million, compared to $4.5 million for the same period in 2009.  2010 revenues included $26.8 million recognized from the $2
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011
    2. Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
    3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Results
    4. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
    5. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
    6. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
    7. Vanda Pharmaceuticals Reports First Quarter 2009 Results
    8. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
    9. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
    10. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
    11. Keryx Biopharmaceuticals to Present at 13th Annual BIO CEO and Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... German . , ... in a semiconductor layer. Quantum dots are small structures that ... a short laser pulse is fired at the photonic crystal, ... a change in the electromagnetic field around it. This change ... by the dot. As soon as the refractive index recovers ...
    (Date:9/30/2014)... YORK , Sept. 30, 2014 ... and segments with highest potential revenues Do you ... updated report gives you revenue predictions for those ... For those therapies you find financial data, R&D ... analysis you get sales forecasts to 2024 at ...
    (Date:9/30/2014)... 2014 Follow us on LinkedIn ... type of cholesterol carrier or lipoprotein in the blood. ... cholesterol levels in the body, especially along the walls ... attack and other cardiovascular disorders. Cardiovascular Diseases (CVD) is ... cholesterol levels on a regular basis, to assess an ...
    (Date:9/30/2014)... OriginOil Inc. (OTC/QB: OOIL), developer of ... clean up large quantities of water, announced today that ... on the launch of the company's CLEAN-FRAC™ industrial grade ... partner STW Resources . , Immediately upon startup, ... (bpd) and achieved a 99.8% reduction in Turbidity on ...
    Breaking Biology Technology:Ultrafast remote switching of light emission 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
    ... all over the globe. Most have a lot of ... about their relevant experiences and capabilities with upfront personalities. ... what is missing is the proof about who really ... management the staff and their true particulars. This information ...
    ... her series of entrepreneurial profiles, this week Teresa reviews ... was published by O'Reilly Press in 2004. , ,Nerds ... good thing. , ,The first essay in Hackers & ... junior high school cafeteria, mapping out lunch tables according to ...
    ... Children's Hospital announced on Tuesday that they have ... purchase the information system CardioIMS. The system will be ... which addresses the needs of children and adults with ... an in-depth study of the Center's administrative and clinical ...
    Cached Biology Technology:Whats Hush-Hush Marketing? 2Whats Hush-Hush Marketing? 3Hackers & Painters: Big Ideas from the Computer Age 2Hackers & Painters: Big Ideas from the Computer Age 3Hackers & Painters: Big Ideas from the Computer Age 4Hackers & Painters: Big Ideas from the Computer Age 5Children's Hospital chooses Camtronics for cardiology IT system 2
    (Date:9/30/2014)... environmental effects of moorland burning is published today in ... the aim of relieving tensions on both sides of ... (Effects of Moorland Burning on the Ecohydrology of River ... which is practised predominantly to support red grouse populations ... hydrology, peat chemistry and physical properties, river water chemistry ...
    (Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
    (Date:9/30/2014)... of Medicine reports positive results of a phase ... subset of lung cancer marked by rearrangement of the ... with advanced non-small cell lung cancer testing positive for ... with 3 complete responses and 33 partial responses. Median ... disease to resume its growth after being slowed by ...
    Breaking Biology News(10 mins):Grouse moor burning causes widespread environmental changes 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
    ... 20, 2012   Cell Therapeutics, Inc. ("CTI") (NASDAQ and ... European Medicines Agency,s ("EMA") Committee for Medicinal Products for ... on CTI,s Marketing Authorization Application ("MAA") for Pixuvri in ... with the CHMP on the Summary of Product Characteristics ...
    ... of scientists has found one of the rarest and least ... was believed to be extinct or on the verge of ... of Primatology , confirms the continued existence of this endangered ... it was previously not known to exist. Miller,s Grizzled ...
    ... flow channels offer a chemically unique environment, which at first ... in the crust of the earth, through which water flows, ... And yet it is precisely this extreme environment, where ... root of all life: The multiplication of biomolecules (reproduction) and ...
    Cached Biology News:Cell Therapeutics, Inc. Expects That the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February 2Cell Therapeutics, Inc. Expects That the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February 3'Extinct' monkey rediscovered in Borneo by new expedition 2Avalanche of reactions at the origin of life 2Avalanche of reactions at the origin of life 3
    96 Well Plate UB, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
    ... Incubated Console Orbital Shakers combine high ... unequalled programming power. The patented ... the unit to run with heavy ... filtration system reduces contamination. The ...
    ...
    ... combine high durability and capacity with ... use. The patented triple-counterbalanced heavy-duty mechanism ... run at high speed with heavy, ... range is delivered with tight uniformity ...
    Biology Products: